Ingredion Incorporated (NYSE:INGR – Get Free Report) CEO James P. Zallie sold 1,000 shares of the stock in a transaction on Monday, August 26th. The stock was sold at an average price of $134.02, for a total transaction of $134,020.00. Following the completion of the transaction, the chief executive officer now directly owns 52,530 shares in the company, valued at approximately $7,040,070.60. The sale was disclosed in a filing with the SEC, which is available through this hyperlink.
Ingredion Trading Down 0.0 %
Shares of INGR opened at $132.65 on Wednesday. The stock has a market capitalization of $8.71 billion, a P/E ratio of 13.29, a PEG ratio of 1.16 and a beta of 0.72. The company has a quick ratio of 1.39, a current ratio of 2.44 and a debt-to-equity ratio of 0.47. The firm has a fifty day simple moving average of $121.29 and a two-hundred day simple moving average of $117.62. Ingredion Incorporated has a twelve month low of $89.54 and a twelve month high of $134.18.
Ingredion (NYSE:INGR – Get Free Report) last announced its quarterly earnings results on Tuesday, August 6th. The company reported $2.87 earnings per share for the quarter, beating the consensus estimate of $2.53 by $0.34. The business had revenue of $1.88 billion during the quarter, compared to analysts’ expectations of $1.98 billion. Ingredion had a net margin of 8.45% and a return on equity of 16.56%. The firm’s revenue for the quarter was down 9.2% compared to the same quarter last year. During the same quarter in the prior year, the company posted $2.32 EPS. On average, research analysts anticipate that Ingredion Incorporated will post 9.7 EPS for the current year.
Institutional Investors Weigh In On Ingredion
Analyst Upgrades and Downgrades
A number of equities analysts have recently commented on INGR shares. StockNews.com lowered shares of Ingredion from a “strong-buy” rating to a “buy” rating in a report on Wednesday, August 7th. BMO Capital Markets increased their target price on shares of Ingredion from $120.00 to $128.00 and gave the company a “market perform” rating in a report on Wednesday, August 7th. Oppenheimer increased their target price on shares of Ingredion from $126.00 to $138.00 and gave the company an “outperform” rating in a report on Wednesday, August 7th. Barclays raised shares of Ingredion from an “equal weight” rating to an “overweight” rating and increased their target price for the company from $122.00 to $145.00 in a report on Friday, August 9th. Finally, UBS Group increased their target price on shares of Ingredion from $141.00 to $148.00 and gave the company a “buy” rating in a report on Thursday, August 15th. One investment analyst has rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $137.33.
View Our Latest Stock Report on Ingredion
Ingredion Company Profile
Ingredion Incorporated, together with its subsidiaries, manufactures and sells sweeteners, starches, nutrition ingredients, and biomaterial solutions derived from wet milling and processing corn, and other starch-based materials to a range of industries in North America, South America, the Asia Pacific, Europe, the Middle East, and Africa.
Featured Stories
- Five stocks we like better than Ingredion
- Health Care Stocks Explained: Why You Might Want to Invest
- Study: How Much Are Retirees Earning from Side Hustles in 2024?
- The 3 Best Retail Stocks to Shop for in August
- Brinker International Offers a Pullback Opportunity on EPS Miss
- Should You Add These Warren Buffett Stocks to Your Portfolio?
- Globant Is an Emerging AI Play That’s Expanding Its Footprint
Receive News & Ratings for Ingredion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ingredion and related companies with MarketBeat.com's FREE daily email newsletter.